Ligand profile
CHEMBL361618
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_2384 — methionine aminopeptidase, type I
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL361618- UniProt (similar protein)
P0AE18- pchembl
- 7.090 (~81.3 nM)
- Target protein
- VK055_2384
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 84.0
- −1 ≤ LogP ≤ 5 2.20
- MW ≤ 500 Da 282.4
- LogP ≤ 5 2.20
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 84.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCC(=O)Nc1scnc1C(=O)Nc1nccs1CCC(=O)Nc1scnc1C(=O)Nc1nccs1
InChI=1S/C10H10N4O2S2/c1-2-6(15)13-9-7(12-5-18-9)8(16)14-10-11-3-4-17-10/h3-5H,2H2,1H3,(H,13,15)(H,11,14,16)InChI=1S/C10H10N4O2S2/c1-2-6(15)13-9-7(12-5-18-9)8(16)14-10-11-3-4-17-10/h3-5H,2H2,1H3,(H,13,15)(H,11,14,16)
FZCZELMDXYJUSC-UHFFFAOYSA-NFZCZELMDXYJUSC-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ sequence
- Source
- ChEMBL
- Binding sites
- PF00557
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL361618 →
- UniProt UniProt P0AE18 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL361618”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_2384.
PDB 46
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).